Inspire Medical Systems, Inc. (INSP) Stock

About Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc. is led by CEO Timothy Herbert, publicly traded since 2018.

Inspire Medical Systems, Inc. (INSP) stock trades at $71.11 with a market capitalization of $2.06B. The stock is valued at a price-to-earnings (P/E) ratio of 15.01, price-to-book of 2.44, price-to-sales of 2.25. Over the past 52 weeks the stock has ranged between $38.91 and $147.03, and currently trades 51.6% below its 52-week high.

On profitability, Inspire Medical Systems, Inc. generates a return on equity (ROE) of 17.62%, above the typical market range of roughly 12-15%, return on capital employed of 6.33%, an operating margin of 5.59%, a net profit margin of 15.03%.

Inspire Medical Systems, Inc. by the numbers, 2016–2025

Between 2016 and 2025 Inspire Medical Systems, Inc. reported revenue of $16.0M rising to $912.0M, a change of +5600.0% across 10 years. Compounded, revenue has grown 51.3% a year over five years, 30.8% over three, 13.6% over the last twelve months. Net profit rose to $145.0M.

Operating margin went from -105.0% in 2016 to 5.6% in 2025, a gain of 110.6 percentage points. The most recent net margin is 15.03%. On a trailing twelve-month basis to Jun '26, revenue is $900.0M and net profit $135.0M.

Borrowings rose from $16.0M to $32.0M, cash from operations was $117.0M in the latest year, positive in 4 of the last 10.

Return on equity has averaged -0.9% over five years, and was 18.6% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Inspire Medical Systems, Inc. (INSP) — frequently asked questions